The 13 references in paper V. Khairutdinov R., A. Mikhailichenko F., A. Piskunova A., N. Bychkova V., A. Samtsov V., E. Imyanitov N., В. Хайрутдинов Р., А. Михайличенко Ф., А. Пискунова А., Н. Бычкова В., А. Самцов В., Е. Имянитов Н. (2014) “ЭКСПРЕССИЯ АДАПТЕРА TH17-ЛИМФОЦИТОВ – TRAF3IP2 В КОЖЕ БОЛЬНЫХ ПСОРИАЗОМ // EXPRESSION OF TH17-LYMPHOCYTE ADAPTER – TRAF3IP2 IN THE SKIN OF PSORIASIS PATIENTS” / spz:neicon:mimmun:y:2011:i:6:p:597-602

1
Интернет-ресурс Национального Центра Биотехнологической Информации (NCBI). Primer-Blast: http://www.ncbi.nlm.nih.gov/tools/ primer-blast/index.cgi?LINK_LOC = BlastHome.
(check this in PDF content)
2
Ellinghaus E., Ellinghaus D., Stuart P.E. et al. Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet. – 2010. – 42 (11). – P. 991-995.
(check this in PDF content)
3
Fischer M., Skowron M., Berthold F. Reliable transcript quantification by real-time reverse transcriptase-polymerase chain reaction in primary neuroblastoma using normalization to averaged expression levels of the control genes HPRT1 and SDHA // J. Mol Diagn. – 2005. – 7 (1). – P. 89-96.
(check this in PDF content)
4
Hacker H., Redecke V., Blagoev B. et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature. – 2006. – 439. – P. 204-207.
(check this in PDF content)
5
Huffmeier U., Uebe S., Ekici A. et al. Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet. – 2010. – 42 (11). – P. 996-9.
(check this in PDF content)
6
Li X., Commane M., Nie H. et al. Act1, an NF-κB-activating protein. Proc Nat Acad Sci USA. – 2000. – 97. – P. 10489-10493.
(check this in PDF content)
7
Liang S.C., Tan X.Y., Luxenberg D.P. et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides // J. Exp Med. – 2006. – 203. – P. 2271-2279.
(check this in PDF content)
8
Liu C., Qian W., Qian Y. et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal. – 2009. – 2 (92): ra63.
(check this in PDF content)
9
Mullenbach R., Lagoda P.J., Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet. – 1989. – 5 (12). – P. 391.
(check this in PDF content)
10
Nestle F.O., Kaplan D.H., Barker J. Review article: Mechanisms of Disease. Psoriasis // New England Journal of Medicine. – 2009. – 361. – P. 496-509. Таблица 2. уРовень эКспРессии мРнК гена TrAF3Ip2 в Коже больных псоРиазом и здоРовых доноРов Категория Количество биоптатов Уровень экспрессии, M±m U-критерий Манна–Уитни Критическое значение UКр p ≤ 0,05 Больные псориазом361,98±0,17* 193,5175 Здоровые доноры141,55±0,24* примечание. * – уровень экспрессии выражен в условных единицах относительной экспрессии; М – среднее значение; m – ошибка среднего значения.
(check this in PDF content)
11
Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation // Immunity. – 2008. – 28. – P. 454-467.
(check this in PDF content)
12
Qian, Y., Liu C., Hartupee J. et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease // Nat. Immunol. – 2007. – 8. – P. 247-256.
(check this in PDF content)
13
Starnes T., Robertson M.J., Sledge G. et al. Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production // J. Immunol. – 2001. – 167. – P. 4137-4140.
(check this in PDF content)